60
Queen Mary Hospital 瑪麗醫院 Queen Mary Hospital 瑪麗醫院 1 Acute Myocardial Infarction Clinical Pathway - The QMH Experience Dr Raymond Chan Consultant Cardiologist Queen Mary Hospital, Hong Kong 8 th Jun 2011 HA Convention 急性心肌梗塞臨床路徑

Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院1

Acute Myocardial Infarction Clinical Pathway -

The QMH Experience

Dr Raymond ChanConsultant Cardiologist

Queen Mary Hospital, Hong Kong8th Jun 2011 HA Convention

急性心肌梗塞臨床路徑

id18690656 pdfMachine by Broadgun Software - a great PDF writer! - a great PDF creator! - http://www.pdfmachine.com http://www.broadgun.com

Page 2: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院2

Part 1 : What is it?What are the Results?

Part 2 : How we do it?How to run a AMI_CP.

It is worth doing & you can do it.Sharing of some difficulties & problem Solving

Page 3: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

3

PART 1: WHAT?

Page 4: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

M/57 Acute MIM/57 Acute MI

M/57 Severe Intense Pain, AMI M/57 Severe Intense Pain, AMI ��EEmergent PPCI (mergent PPCI (PPrimary rimary PPercutaneous ercutaneous CCoronary oronary IIntervention) done.ntervention) done.Patient well. Discharge home 3 daysPatient well. Discharge home 3 days

LADLAD

CIRCIRCIRCIR

Before PCI After PCI

LAD locked

Page 5: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院5

Unstable Angina心絞痛

Non-ST Elevation MI

ST Elevation MI

心肌梗塞

急性冠狀動脈綜合症Acute Coronary Syndrome

SPECTRUM

Page 6: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院

6

The Scope:The Scope:

ACS Accounts for 10,000admissions to HA Hospitals

QMH (2009) -617 AMI�s (227 STEMI + 390 NSTEMI)

Page 7: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院7

The Significance :The Significance :

Half of AMI�s are fatal.

Out of all fatalities, majority died before patients arrive to Hospital

(WHO Monica Study & AIHW Database)

Page 8: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

It is a well-written clinical protocol based on updated international guidelines.

It�s placed & starts at the AED, consist of a booklet of practical, didactic clinical instructions with check boxes on what the doctors & nurses should do starting atDay 1-5 aiming to cater for >90% ofpatients of Uncomplicated AMI.

The Clinical Pathway The Clinical Pathway �� What is it ?What is it ?

8

PART 1: WHAT?

1. Decision making criteria for the use & Contraindications of Lytics or PPCI

2. Logistics to activate the operation team3. Use of medications4. Step down criteria 5. Daily care map until discharge

Page 9: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Inception of AMI_CP 2006

With the Vision of Dr WH Seto & Dr Lawrence Lai, the QMH sent a team of 10 delegates to Singapore Changi Hospital to learn about their Practice of Clinical pathways

10 members: WH Seto, Alan Wong, Kate Choi, Patricia Ching, Sania, WC Ho, NF Shum, TW Lau, T Li, SK Leung, R Chan

Acute Myocardial Infarction Acute Myocardial Infarction -- Clinical PathwayClinical Pathway

9

Page 10: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Acute Myocardial Infarction Acute Myocardial Infarction -- Clinical PathwayClinical Pathway

107.2006

Prof Fock Kwong Ming

Page 11: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

(1.2.2007 1st version)

11

Page 12: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

12

� When a coronary artery is blocked, the most important Rx is to open it ASAP

� Timing is critical

� Given the right time, right place, PPCI is better, the matter is resource & logistics

� Patients triaged by the CP to Lytics (SK or TNK) or PPCI

� Daily Care-map

Page 13: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Daily Drug(Class 1) PrescriptionBoxes

Page 14: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

(1.2.2007 1st version)

14

Page 15: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

(1.2.2007 1st version)

15

Page 16: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

16

UnCx AMI 2007 2008 2009 2010

No. recruit 201 160 174 119

No. Completed 166 123 113 89

= 654

75.1% (491) of the patients completed the CP from 2007-2010

Patients completed CP 491Patients receiving Thrombolytics 95 (38 +36 +16 + 5)Patients receiving PPCI 176 (23 +36 +57 +60)

2007 2008 2009 2010

654 Un-Complicated AMI pts were recruited since 2007

Page 17: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

17

Total AMI 2007-2010 = 617 x 4 = 2468(CP Recruits) 654/ 2468 = 26.5%(Excl fallout pts) 491/ 2468 = 20% of AMI in the CP

We hypothesized that by running a AMI_CP on a targeted group of STEMI patients, it exerts a �TRAILER TRUCK� effect on the Q.O.C. of

other AMI patients � STEMI & NSTEMI alike

How can we tell?By examining the Clinical outcome of ALL the AMI patients throughout the years since the inception of the AMI CP.

Page 18: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Circulation, AHA, Guidelines for Management of STEMI Update 2011Door to Needle Time(DNT) ≤ 30 min Door to Balloon Time(DBT) ≤ 90 min

Mortality(%) of 2,245 pts in National Infarct Angioplasty Project (NIAP), UKPrimary PCI better than Thrombolytics with better outcome :

Caveat � right place, right time DBT � DNT <= 60�

Stroke 2000; 31; 1802Stroke 2000; 31; 1802--18111811Risk Factors for Intracranial haemorrhage (ICH) after Thrombolytics:

Age >=75y BW F<=65kg M<=80kg Female SBP>=160mmHgPrior Stroke TNK use Black Race INR>=4

Numerous Drugs Trials for AMI Numerous Drugs Trials for AMI ��Aspirin, Plavix, Beta Blocker, ACEI, ARB, StatinsAspirin, Plavix, Beta Blocker, ACEI, ARB, Statins 18

Treatment 30 days 1 year 18 monthsPPCI 5.6 8.7 9.9Thrombolysis 7.9 12.4 14.8No Reperfusion 16.4 28.3 31.0

EBM � Fundamental of AMI Clinical Pathway

Page 19: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH AMI_CLINICAL PATHWAY :

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院19

RESULTS

PART 1: WHAT?

Page 20: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

2007 2008 2009 2010 1-4/2011 International Benchmark

No. Recruited 201 160 174 119

No. Completed 166 123 113 89

Age (mean) 68.1 65.8 63 65.3

Lytics 38 (22.9%) 36(29%) 16(14%) 5 (5.6%) xD-N-T (mean) 86 42 40 43 x 30

PPCI 23(13.9 %) 36(29%) 57(50%) 60(67.4%)

D-B-T (mean) 277 113 101 96 90

LOS (mean) 5.2 4.2 3.9 4

Readmission Rate

6.6 4.1 4.4 5.6

Hosp Mortality(All AMI)

13.2 10.5 10.2 9.8 See Chart

Results 1: AMI Clinical Pathway 2007 - Present:

Page 21: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

2007 2008 2009 2010 1-4/2011 International Benchmark

No. Recruited 201 160 174 119

No. Completed 166 123 113 89

Age (mean) 68.1 65.8 63 65.3

Lytics 38 (22.9%) 36(29%) 16(14%) 5 (5.6%) xD-N-T (mean) 86 42 40 43 x 30

PPCI 23(13.9 %) 36(29%) 57(50%) 60(67.4%)

D-B-T (mean) 277 113 101 96 90

LOS (mean) 5.2 4.2 3.9 4

Readmission Rate

6.6 4.1 4.4 5.6

Hosp Mortality(All AMI)

13.2 10.5 10.2 9.8 See Chart

Results 1: AMI Clinical Pathway 2007 - Present:

Page 22: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

International Database of AMI Mortality

16.00% 9.80% 7.20%

48.9%

14.5%

49.4%

19.00%22%

0%20%40%60%80%

100%

AIHW TotalCFR

AIHW hospCFR

WHOMONICA28d CFR

(Men)

WHOMONICA28d CFRHosp pts

(Men)

YALEMedicare30d, JGIM

2006

Yale 201030d RSMR,Circ Cardio

Outcome2010

HK HA AmiMortality

Study 2009,in progress

HK QMH2010 In-

Hosp CFR

SwedishSTEMI

Registry1996-2007In-HospMortality

JAMA 2011

per

cen

tag

e

Circulation 1997:WHO Project withA population view 1985-1990

Australian Institute of Health & Welfare 9.2002: 1/2 of 48,313 events were fatal (1999-00) & 87% occurred outside hospital

THE IMPACT

LIMITATIONS: AIHW 2002 WHO 1990 MEDICARE FFS CCU Pt only½US AMI Pts

MortalityTrend

MortalityTrend

* * *

Page 23: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

International Database of AMI Mortality

16.00% 9.80% 7.20%

48.9%

14.5%

49.4%

19.00%22%

0%20%40%60%80%

100%

AIHW TotalCFR

AIHW hospCFR

WHOMONICA28d CFR

(Men)

WHOMONICA28d CFRHosp pts

(Men)

YALEMedicare30d, JGIM

2006

Yale 201030d RSMR,Circ Cardio

Outcome2010

HK HA AmiMortality

Study 2009,in progress

HK QMH2010 In-

Hosp CFR

SwedishSTEMI

Registry1996-2007In-HospMortality

JAMA 2011

per

cen

tag

e

Circulation 1997:WHO Project withA population view 1985-1990

Australian Institute of Health & Welfare 9.2002: 1/2 of 48,313 events were fatal (1999-00) & 87% occurred outside hospital

THE IMPACT

LIMITATIONS: AIHW 2002 WHO 1990 MEDICARE FFS CCU Pt only½US AMI Pts

MortalityTrend

MortalityTrend

* * *

Page 24: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH EXPERIENCE : Causes Overall AMI Mortality :

367

65

44

30

361

104

63

25

465

64

93

10

476

36

87

5

110

13

40

0

2007 2008 2009 2010 2011

ELECTIVE

URGENT

EMERGENCY

LYTICS

EMERGENT PCI :Procedure be performed ASAP/ within 24h(Maj = PrimaryPCI)

URGENT PCI :Procedure be performed within index hospitalisation

(Jan-Mar)

*

E-PCI : ∑ Mort RateNon UR ( =NON ULTRA RISK)UR (Shock, Post Arrest, Intub, VT)Elective PCI :

∑ 4.3%(4/93)2.8%(2/72)9.5%(2/21)

0%

∑ 8.1%(7/87)0%(0/66)

33.3 %(7/21)0%

∑ 6.8% ∑ 7.9%

13.2% 10.5% 10.2% 9.8%OverallAMI Mortality

(E-PCI)

24 Hour PPCI7.11.2010

Page 25: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

25

% within 24h Non-Compliance Reason

Aspirin 94.3 Allergy to Aspirin; Anaemia on admissionBleeding tendency on admission e.g. low PLT countAlready on anti-coagulation drug e.g. Warfarin

Plavix 85.4 Patients started Plavix on Day 2,6,8 and 16

% Upon Discharge Non-Compliance Reason

Aspirin 97.6 Allergy to Aspirin; Anaemia Bleeding tendency e.g. low PLT countAlready on anti-coagulation drug e.g. Warfarin

Plavix 88 Stopped Plavix for performing CABG

Beta Blocker 84.6 Lowish BP; Relative low heart rate; Heart BlockHistory of COPD or COPD on exacerbation

ACEI / ARB 73.2 Lowish BP; Deranged renal function; Already on ARB

Statins 95.9 Normal lipid levelFasting lipid profile result not available on discharge from QMH & would be follow up in CRP bed or in cardiac SOPD

Results 2 : Drug Compliance Audit 2007 (UK NICE Criteria)

Page 26: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

26

AMI CP (Key Performance Indicators)

0

50

100

150

200

250

300

Year

DNT DBT (min)

0

2

4

6

8

10

QuarterLOS (days)

DNT DBT LOS

DNT 86 111 114 41 45 35 35 39.5 42 20 40 50 0 43 43 61 0

DBT 277 127 188 106 120 104.5 106 97 101 101 105 105.5 96 89 99.5 101 119

LOS 4 4 4 3 3 3 3 5 3 4 4 3 4 4.6 3.52 4 2

MOR 13.19 10.49 10.23 9.76

RAM 6.63 4.07 4.42 5.62

2007 2008 2009 2010 2011

* Declining Mortality Trend in ALL AMI Patients

*

Page 27: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Mortality Trend � Contributing factors :

Short DNT � phased out 7.11.2010 Short DBT Near 100% compliance for eligible pts receiving medications of

Class I indications Strategic phasing out of administration of IV Lytics & the 24 hour

Emergent Primary PCI Program

(High percentage of high risk patients achieve target LDLC <70mg/dL = 82.9% ) � Complex Correlation, Not discussed in the present context

Acute Myocardial Infarction : Clinical PathwayAcute Myocardial Infarction : Clinical Pathway

27

END OF PART 1: �WHAT� & THE IMPACT

Page 28: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院28

Part 2

How To Do It?

PART 2: HOW?

Page 29: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院29

It is Labour Intensive but HAPPY!

Page 30: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院

��QMH Acute Myocardial Infarction QMH Acute Myocardial Infarction Clinical Pathway TeamClinical Pathway Team��

ER

Audit & CQI

MSW

CARDIOLOGISTS

Radiographers, CCL Nurses

CCU & Ward

Physio, OT, Dietitian

Page 31: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院31

1.Open, Fair & Transparent �

How to do that ?

PART 2: HOW TO RUN A AMI CP?

Page 32: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH Audit, Training & Development TeamQMH Audit, Training & Development Team Review & develop Review & develop SOPSOP & C& Care Mapsare Maps Root cause analysisRoot cause analysis of Variances ( of Variances ( DNT, DBT & LOS)DNT, DBT & LOS) Case managerCase manager : Data acquisition, Analysis, Variance audit: Data acquisition, Analysis, Variance audit

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院

Selina WongDOM

Pearl ChanSNO T&D Patricia Ching

SNO Q & S

Kate ChoiSNO CAM

Sania KwanQRI

Wong So ManCase Manager

Page 33: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH Audit, Training & Development TeamQMH Audit, Training & Development Team Review & develop Review & develop SOPSOP & C& Care Mapsare Maps Root cause analysisRoot cause analysis of Variances ( of Variances ( DNT, DBT & LOS)DNT, DBT & LOS) Case managerCase manager : Data acquisition, Analysis, Variance audit: Data acquisition, Analysis, Variance audit

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院

Selina WongDOM

Pearl ChanSNO T&D Patricia Ching

SNO Q & S

Kate ChoiSNO CAM

Sania KwanQRI

Wong So ManCase Manager

B R A I NB R A I N

Page 34: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

RESULTS

REVIEW& AUDIT

CHANGE & INTERVENE

CLNICAL PRACTICE

PART 2: HOW?

Form the Basisof Interactive

Model

Page 35: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院35

2. Strategic Reviews are Essential

Highlight How the Interactive Model works?

PART 2: HOW?

Page 36: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Lytics may result in Fatal Complications Lytics may result in Fatal Complications ��

36

2003 (TNK) 2005 (TNK)2007 (TNK) 2007 (SK)2008 (TNK)

We performed extensive review into previous clinical data.

Lytic is dangerous

RESULTS

REVIEW& AUDIT

CHANGE & INTERVENE

CLNICAL PRACTICE

Page 37: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

PPRIMARY RIMARY PPERCUTANEOUS ERCUTANEOUS CCORONARY ORONARY IINTERVENTIONNTERVENTION

37

Symptom onset : 11:20 3/11/07 VFDoor time : 12:08 3/11/07 QMH

Balloon time : 13:35 3/11/07 Door-to-Balloon Time : 87min

Mechanical VentilationShock, IABP

Normal Flow Re-establishedPt in ICU 2 weeksAcute Renal FailureNo Urine, depend on HD

No Left SystemTotal Blocked LAD

*1******* 2

3 4

PPCI is moreEfficacious & safer& may represent the only optione.g. when Lytics are C/I, shock, late presentation

Major Issue isresource

*1*******

*1******* *1*******

RESULTS

REVIEW& AUDIT

CHANGE & INTERVENE

CLNICAL PRACTICE

Page 38: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

38

Balloon time : 13:35 3/11/07 Door-to-Balloon Time : 87min

Normal Coro Flow EstablishedPt in ICU Acute Renal Failure 6wFull recovery

*1******* 2

3 4

*1*******

*1******* *1*******

6 weeks later, in the clinic, he told me�Doctor, its Dribbling� � I did not believe

1w later, he told me �Doctor its like a Fountain�He tried to convince me and took out

a bottle of yellow liquid � O Yes I believe!

TO OUR TEAM, THIS IS A MIRACLE.HOWEVER WE KNOW THAT

IF WE DID NOT DO IT, MIRACLES WON�T HAPPEN!

xxxxxxxx xxxxxxxxxx

Page 39: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

From international studies & our own Hospital Data, we know that Lytics are potentially hazardous & PPCI superior

We took a cautious start on1/2/2007 9A � 5P PPCI

1st Upgrade 1/8/2008 8A � 8P(*ICH = Intracranial bleeding)

2nd Upgrade 15/4/2009 24h PPCI (Pts ≧2 Risk Factors ICH*)

3rd Upgrade 7/11/2010 24h PPCI for all eligible Pts

Prior to each Upgrades, we perform PRESSURE TESTING39

PART 2: HOW?

18m

8m

18m

Page 40: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

40

9a 5p

8A 8P 8A

PPCI 2007(No. of Patients)

2008(No. of Patients)

2009(No. of Patients)

2010(No. of Patients)

08:00 � 08:59 1 2 2 5

09:00 � 17:00 17 23 34 32

17:01 � 20:00 3 10 9 8

20:01 20:01 �� 07:5907:59 1 1 12 15

Lytics 2007(No. of Patients)

2008(No. of Patients)

2009(No. of Patients)

2010(No. of Patients)

08:00 � 08:59 0 1 0 0

09:00 � 17:00 11 8 1 1

17:01 � 20:00 7 5 2 0

20:01 20:01 �� 07:5907:59 20 22 13 5

E-PPCI System PRESSURE TESTING & Contextualization

1.2.2007

1.8.2008 15.4.2009

7.11.2010` 1.8.2008 15.4.2009

NightFall

DawnDawn

(18m) (8m)

(18m)

Page 41: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

41

9a 5p

8A 8P 8A

PPCI System Pressure Testing & Contextualization Process

1.2.2007

1.8.2008 15.4.2009

7.11.2010

Change of number of patients undergoing PPCI in different period

0

10

20

30

40

50

60

70

2007 2008 2009 2010

Num

ber

of p

atie

nts

08:00 � 08:59 09:00 � 17:00 17:01 � 20:00 20:01 � 07:59

25

Page 42: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

42

9a 5p

8A 8P 8A

PPCI System Pressure Testing & Contextualization Process

1.2.2007

1.8.2008 15.4.2009

7.11.2010

Change of the number of patients using LYTICS in different period

0

5

10

15

20

25

2007 2008 2009 2010

Num

ber

of p

atie

nts

08:00 � 08:59 09:00 � 17:00 17:01 � 20:00 20:01 � 07:59

Page 43: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Mean Door to Thrombolysis Time

W.e.f. 31 Aug 07, Re-rectified that Lytics be given in AED for eligible patients; Cardiology Consult was carried out only if essential. (refer to �System Intervention� slide)

W.e.f. 1 Aug 08, Cath. Lab. Extended service to 08:00 � 20:00 hrs

Minutes

45.0035.00 35.00

99.11

138.55 144.88

38.00

51.3338.00

80.00

86.00

116.00

41.00

114.00

0

20

40

60

80

100

120

140

160

8Jan07 to 31Mar07

1Apr07 to30Jun07

1Jul07 to30Sept07

1Oct07 to31Dec07

1Jan08 to31Mar08

1Apr08 to30Jun08

1Jul08 to30Sept08

MeanMedian

43

RESULTS

REVIEW& AUDIT

CHANGE & INTERVENE

CLNICALPRACTICE

PART 2: Other Interactive Examples

Page 44: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Door to Balloon Time

124.78117.13

153.43140.88182.25131.00

277.00

127.00104.50

120.00106.00

188.00

127.00

277.00

0

50

100

150

200

250

300

8Jan07 to31 Mar07

1Apr07 to30Jun07

1Jul07 to30Sept07

1Oct07 to31Dec07

1Jan08 to31Mar08

1Apr08 to30Jun08

1Jul08 to30Sept08

Minutes

Mean

Median

44

RESULTS

REVIEW& AUDIT

CHANGE & INTERVENE

CLNICAL PRACTICE

Regular Review Meetings & seek for improvements

Page 45: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Mean LOS

Implementation of AMI CP w.e.f.

8Jan07

4.58

2.803.68

3.934.03

5.28

4.09

5.02

4.66

0

1

2

3

4

5

6

2005 2006 1Q 2007 2Q 2007 3Q 2007 4Q 2007 1Q2008 2Q 2008 3Q 2008

No. of Days

45

RESULTS

REVIEW& AUDIT

CHANGE & INTERVENE

CLNICALPRACTICE

Examine all Variance cases

Page 46: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

4 Cardiology specialty trainees were recruited into the team since 1 Jul 2007 A B C

With effect from 31 Aug 07, we re-rectify the practice to administer Lytics in AED; Cardiology Consult was carried out only if essential.

A W.e.f. 1 July 2007, AED sent an Emergency Medicine Fellow for elective to

CCU for 3m A B Enhanced Division communication by weekly frontline team meeting in CCU

A B C Regular case review meetings with AED

A B Case Manager involvement in patient education & risk factors identification

C Stepwise Extension of Catheterization Laboratory service since 1.8.2008

C

System Interventions 2007, 2008: A Summary

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院

A. Shorten DN-T B. Shorten DB-T C. Shorten LOS46

PART 2:

Page 47: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院47

3. Manpower Logistics

PART 2: HOW TO RUN A AMI CP?

Page 48: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院48

To Run a PPCI Program, Prerequisites

1. Unit (Program) has to have a critical no.of staff *

2. Expertise, Staff Training & Update3. Commitment: Intense Collaborations

* It can be Program based, with team up of expert persons - Nurses, Radiographers, Doctors alike from cluster hospitals & work on a destined site.

PART 2: HOW?

Page 49: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH 24 Hour Emergent Primary PCI for STEMI

3 Teams to run Emergency Cath Lab 24 hours =

Cath Lab Nurses : 5 (no �Technician� post in QMH CCL)3 Nursing Teams (2 nurses each, 1 additional nurse from the CCU) - weekly rotations

Radiographer : 1 (Daily standby rota)

Cardiologists : (For PCI = Need 1 Interv Cardiologist + 1 Cardiac Fellow)

Interv Cardiologist A � All Mon, Wed, FridaysInterv Cardiologist B � All Tues, Thurs, Sat, Sun

� SERVICE PLEDGE� OFF Site Call - ALL personnels on site within 1 h of call *

PART 2: HOW?

Page 50: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

Important Principles in Team Building

法 理 情

Is it Legitimate? Is it Reasonable? Is it Considerate?

50

Discussion Slides

Page 51: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

51

法On Call system & Compensation:We have three Team of Nurses on weekly off-site call.Each Team is composed of 2 nurses.Therefore they will have 52 x 2 Sundays + 17 x 2 PH (Total = 138 days) to compensate.

Now the compensation system is =For Sundays:If the staff does not need to come back or come back to work less than 4h � One Saturday off will be compensatedIf the staff comes more than 4h � One Weekday will be compensated

For PH:If the staff does not need to come back � One Saturday off will be compensatedIf the staff comes back to work for whatever length of time � One Weekday off will be compensated

Discussion Slides

Page 52: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

52

理 情Compassionate off after on-call work:

If the staff come back to work & off before 12 Midnight �she should work as usual the next day.

If the staff come back to work & off before 4am �she may take the next day morning off for rest

If the staff come back to work & off after 4 am �she may take the next day off for rest.

(Our previous emergency patient statistics is = Staff need to work after 4 am ~ once every 2 months).

TENSILITY & FLEXIBILITYImportant Rule of Thumb : * YOU MUST consider your staff first *

Discussion Slides

Page 53: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

53

38 37

67

50

6

24 25 26

02

6

11

0

10

20

30

40

50

60

70

80

08:01 - 16:00 16:01 - 24:00 00:01 - 08:00

2007

2008

2009

2010

Time of Performing E-PPCI

Time

No.

of

Cas

es

2007 2008 2009 2010 2007 2008 2009 2010

Page 54: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

24 Hour Emergent Primary PCI for STEMI

Resource Issues, some Thoughts

It will be upto the individual Hospital�s Strategic Planning & internal allocation of resource

Central Support + a �Direction Sense� is Important (Cannot be didactic because of local differences)

Re-organisation of Service model eg Program/Cluster base may be further explored

PART 2: HOW?

Page 55: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH AMI_CLINICAL PATHWAY :

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院55

4. Human Touch

PART 2: HOW?

Page 56: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH AMI_CLINICAL PATHWAY :

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院56

� Our Experience, the CP is not a Top-down process, rather an experiential ( experimental) journey of the frontliner

�We know that by following the CP, patients will have a better chance of survival.

�We see miracles

�In the process, we build up an enviable Team with motivation, determination & highly professional.

�We feel we are doing the right thing

PART 2: HOW?

Page 57: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

QMH AMI_CLINICAL PATHWAY :

Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院57

CONCLUSIONS

Part 1 & 2

Page 58: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

THE QMH HEART CENTREBird�s eye view of the Present & Future; (Original version 24.3.2007) Updated 28.5.2011

ADULT CARDIOLOGYCARDIOTHORACIC

SURGERYPAEDIATRIC

CARDIOLOGY

K19N Cath Lab x2CCU 8 bed Cardiac Ward 16 bed

F5-OT D5-Ward C5/E5-ICU CG-Cath Lab x1 A5-Ward

Joint venture- Heart Transplant Program- Tues am Pre-op Echo- Tues pm Join Preop con- PAC at D5

OPD�SS6 Cardiac x2S6 ICD/PPMS7 Arrhythmia x1C1 GS/PenJ1 Private

Laboratories

Non-Invasive InvasiveAG/ K19S-side Cath Lab K19N

2 echos 2 echos2 treadmill 1 treadmillHoltersCardiomemos LindaAmbu BP�s Sam (NO)

Yin Wah (NO)Peter Chan (NO) SharfaHau Yee, Cecilia, Yuen Yee EstherKelly, Winnie, Dorothy Wah Fong

Alta Kan (WM)

Florence (NO)Siu Kum (NO)Lorraine (NO)

Mei LinHarbinderOliverPui MingJackieWai LingMei YiPik SamMan SinVeniceDoraBeckyWinnyNancyPun TuenCorinaGraceLee Wai ManEdwinChung YanAu Tat LongRaymond WanEugenia LawAh Bo (PT)

SUBSPECIALTIES

INTERVEN PACE Clin car Clin Car Heart Failure ECMO Congenital StemCARDIO & Echo & CMR & Transplant Heart Ds Cell

S Lee R Chan YM Lam C Chan YM Lam KL Wong YM Lam D SiuR Chan HF Tse C Chan YM Lam C Chan HF Tse L Lam D Siu K ChanYM Lam

(Fellows: PH Chan, JJ Hai, S Lam, K Chan, KL Wong, Frankie Tam, Arthur Yung, Anthony Wong)

YC Pan,TF Tse,R Wang,W Chen,PK Lee,KK Chan,CK Lau,SF Chow,KK Hui,KS Ho,CH Cheng,SL Lo,YT Tai,CK Wong,D Ho,CP Lau,W Ng,PY Lee,WH Chen

Pwh- Yu, Eugene Fung(N), Joseph Yu,G Yip - Yu mo(Brompton) -Qeh- Duncan, Mike,KT Sam,Tsang(o),So(o) Ho - - Boron -Pyn- Tse Tat Sun, Kin KK Chan,Choi (Aus) Tsui Ko(Berlin) - - -Uch- CK Chan Yu Chiu Sun Leung - - - -Pmh- Wu cw,Tsui pt Mok, Chan ny Ting,choi - - - -Tmh- Chow Liang, Tse Steve Lai -Gh � Chow WH ,Jim K Fan - - (Elaine Chau 2sessions/w) - -Rh � Lau Wong mh Keung - - - -Kwh-Leung Sum kin Leung Sum kin - - - - -

GH Adult Cardiology/ TWH Cardiology / CRPMedical Rehab beds

20 + 20 6 + 62 Con, 2 AC, 5 MO�s (1 Con) 1 MO

(KLC,, TM Tse,CW Lo,OH Kwok,P Hon,FL Kay,CH Lee,WF Lam)

Ground-workAMI Pathway Dg policy(SFI/Special): Statin,Bosentan,Via

CMS-coro,Holter Human Resources- RA,CO,RNPAC system HAHO/ CCC / CTDAG / HKCPCommunity: Legco/PRO/Black/News/Firewall

ICU 1: 1 CCU/HDU/BMT - 1: 2.1

CCU / K19A / P 3 / 3 + NO

N 3 / 1

17 CCU + 7 CWJoint venture ACHD- Adult Congenital Heart Clinic

J1 Structural Monday pmJ2 Arrhythmia Tuesday pmJ3 Echo Clinic Wed pm

Page 59: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

59

CONCLUSION:

AMI is a disease that haunts the developed world & carries a high Mortality & Morbidity. Our experience is that the Clinical Pathway fosters an efficient & responsible management with favourable outcomes. It is a mangement system that is labour intensive & require sophistication, determination & collaborations. It is achievable in QMH & we believe it will also be achievable in other HA Hospitals.

Page 60: Acute Myocardial Infarction Clinical Pathway - The QMH ... · The Clinical Pathway ŒWhat is it ? 8 PART 1: WHAT? 1. Decision making criteria for the use & Contraindications of Lytics

�Serve With Heart�Queen Mary Hospital

瑪麗醫院

Queen Mary Hospital

瑪麗醫院

��QMH Acute Myocardial Infarction QMH Acute Myocardial Infarction Clinical Pathway TeamClinical Pathway Team��

ER

Audit, T & D, CQIMSW

CARDIOLOGISTS

Radiographers, CCL Nurses

CCU & Ward Physio, OT, Dietitian

THANK YOU!